Patents by Inventor Mami INOUE

Mami INOUE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MEDICAMENT FOR TREATING CANCER COMPRISING OPTICALLY ACTIVE AZABICYCLO RING DERIVATIVE
    Publication number: 20260248787
    Abstract: The present invention relates to suitable usage, dosage, and use of an optically active azabicyclo ring derivative useful as a medicament, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising it.
    Type: Application
    Filed: March 31, 2025
    Publication date: August 27, 2026
    Applicant: Sumitomo Pharma Co., Ltd.
    Inventors: Ken EGUCHI, Akinobu WATANABE, Taeko KUSUDA, Mami INOUE, Takafumi SHIMIZU, Mariko MATSUBARA, Takahiro KUWAKI, Matthew HITRON, Hongliang CAI, Bo XU, Emily BROOKS, Curtis ALLRED, Vishnu PEDDAGALI
  • MEDICAMENT FOR TREATING CANCER COMPRISING OPTICALLY ACTIVE AZABICYCLO RING DERIVATIVE
    Publication number: 20260027114
    Abstract: The present invention relates to suitable usage, dosage, and use of an optically active azabicyclo ring derivative useful as a medicament, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising it.
    Type: Application
    Filed: October 30, 2024
    Publication date: January 29, 2026
    Applicant: Sumitomo Pharma Co., Ltd.
    Inventors: Ken EGUCHI, Akinobu WATANABE, Taeko KUSUDA, Mami INOUE, Takafumi SHIMIZU, Mariko MATSUBARA, Takahiro KUWAKI, Matthew HITRON, Hongliang CAI, Bo XU, Emily BROOKS, Curtis ALLRED, Vishnu PEDDAGALI
  • MEDICAMENT FOR TREATING CANCER COMPRISING OPTICALLY ACTIVE AZABICYCLO RING DERIVATIVE
    Publication number: 20250295663
    Abstract: The present invention relates to suitable usage, dosage, and use of an optically active azabicyclo ring derivative useful as a medicament, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising it.
    Type: Application
    Filed: March 31, 2025
    Publication date: September 25, 2025
    Applicant: Sumitomo Pharma Co., Ltd.
    Inventors: Ken EGUCHI, Akinobu WATANABE, Taeko KUSUDA, Mami INOUE, Takafumi SHIMIZU, Mariko MATSUBARA, Takahiro KUWAKI, Matthew HITRON, Hongliang CAI, Bo XU, Emily BROOKS, Curtis ALLRED, Vishnu PEDDAGALI